CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis

Abstract Background Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons, leading to motor and non-motor symptoms. Despite advances in PD research, the molecular mechanisms underlying its pathogenesis remain incompletely understo...

Full description

Saved in:
Bibliographic Details
Main Authors: Kai Wang, Langfeng Zhu, Zhibo Ren
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06602-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849730804477853696
author Kai Wang
Langfeng Zhu
Zhibo Ren
author_facet Kai Wang
Langfeng Zhu
Zhibo Ren
author_sort Kai Wang
collection DOAJ
description Abstract Background Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons, leading to motor and non-motor symptoms. Despite advances in PD research, the molecular mechanisms underlying its pathogenesis remain incompletely understood. Recent studies have highlighted the potential role of circular RNAs (circRNAs) in neurodegenerative diseases. This study aims to investigate the regulatory role of circPRDM5 in PD, focusing on its interactions with miR-433-3p and HDAC6. Methods Bioinformatics tools were used to identify circPRDM5 and its potential interaction with miR-433-3p. Peripheral blood samples were collected from 20 PD patients and healthy controls to measure circPRDM5, miR-433-3p, and HDAC6 expression. For in vivo studies, an MPTP-induced PD mouse model was established, and circPRDM5 knockdown was achieved via tail vein injections of shRNA constructs. Behavioral tests, histological analysis, and immunohistochemistry were used to evaluate motor function and neuronal integrity. In vitro, SH-SY5Y neuroblastoma cells were treated with MPP⁺ to induce PD-like characteristics, followed by transfection with circPRDM5 knockdown constructs and miR-433-3p mimics or inhibitors. Cell viability, lactate dehydrogenase (LDH) release, apoptosis, and autophagy were measured through CCK-8 assay, flow cytometry, western blotting, and immunofluorescence. Results CircPRDM5 expression was significantly elevated in PD patients and MPTP-induced PD mice, with knockdown of circPRDM5 alleviating motor deficits and neuronal damage in vivo. In vitro, circPRDM5 knockdown in SH-SY5Y cells reduced MPP+-induced cellular damage, apoptosis, and autophagy. Bioinformatics analysis identified miR-433-3p as a target of circPRDM5, and its downregulation in PD patients and MPP+-treated cells was observed. Dual-luciferase and RNA pull-down assays confirmed that circPRDM5 functions as a sponge for miR-433-3p, which regulates HDAC6 expression. HDAC6 was found to be upregulated in PD and contributed to neuronal damage. Furthermore, HDAC6 overexpression reversed the protective effects of circPRDM5 knockdown, highlighting the role of the circPRDM5/miR-433-3p/HDAC6 axis in PD pathology. Conclusions This study reveals that circPRDM5 promotes neuronal damage in PD by sponging miR-433-3p and upregulating HDAC6, contributing to apoptosis and autophagy. Knockdown of circPRDM5 reduces PD-like symptoms in both cellular and animal models, providing a potential therapeutic target for PD. Targeting the circPRDM5/miR-433-3p/HDAC6 axis may offer new opportunities for disease-modifying treatments in PD.
format Article
id doaj-art-f4fdc2eed8124593aad0b0582a2e4e85
institution DOAJ
issn 1479-5876
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-f4fdc2eed8124593aad0b0582a2e4e852025-08-20T03:08:44ZengBMCJournal of Translational Medicine1479-58762025-05-0123112010.1186/s12967-025-06602-3CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axisKai Wang0Langfeng Zhu1Zhibo Ren2Department of Pediatric Surgery, The Affiliated Hospital of Qingdao UniversityDepartment of Pediatric Surgery, General Hospital of Ningxia Medical UniversityDepartment of Pediatric Surgery, General Hospital of Ningxia Medical UniversityAbstract Background Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons, leading to motor and non-motor symptoms. Despite advances in PD research, the molecular mechanisms underlying its pathogenesis remain incompletely understood. Recent studies have highlighted the potential role of circular RNAs (circRNAs) in neurodegenerative diseases. This study aims to investigate the regulatory role of circPRDM5 in PD, focusing on its interactions with miR-433-3p and HDAC6. Methods Bioinformatics tools were used to identify circPRDM5 and its potential interaction with miR-433-3p. Peripheral blood samples were collected from 20 PD patients and healthy controls to measure circPRDM5, miR-433-3p, and HDAC6 expression. For in vivo studies, an MPTP-induced PD mouse model was established, and circPRDM5 knockdown was achieved via tail vein injections of shRNA constructs. Behavioral tests, histological analysis, and immunohistochemistry were used to evaluate motor function and neuronal integrity. In vitro, SH-SY5Y neuroblastoma cells were treated with MPP⁺ to induce PD-like characteristics, followed by transfection with circPRDM5 knockdown constructs and miR-433-3p mimics or inhibitors. Cell viability, lactate dehydrogenase (LDH) release, apoptosis, and autophagy were measured through CCK-8 assay, flow cytometry, western blotting, and immunofluorescence. Results CircPRDM5 expression was significantly elevated in PD patients and MPTP-induced PD mice, with knockdown of circPRDM5 alleviating motor deficits and neuronal damage in vivo. In vitro, circPRDM5 knockdown in SH-SY5Y cells reduced MPP+-induced cellular damage, apoptosis, and autophagy. Bioinformatics analysis identified miR-433-3p as a target of circPRDM5, and its downregulation in PD patients and MPP+-treated cells was observed. Dual-luciferase and RNA pull-down assays confirmed that circPRDM5 functions as a sponge for miR-433-3p, which regulates HDAC6 expression. HDAC6 was found to be upregulated in PD and contributed to neuronal damage. Furthermore, HDAC6 overexpression reversed the protective effects of circPRDM5 knockdown, highlighting the role of the circPRDM5/miR-433-3p/HDAC6 axis in PD pathology. Conclusions This study reveals that circPRDM5 promotes neuronal damage in PD by sponging miR-433-3p and upregulating HDAC6, contributing to apoptosis and autophagy. Knockdown of circPRDM5 reduces PD-like symptoms in both cellular and animal models, providing a potential therapeutic target for PD. Targeting the circPRDM5/miR-433-3p/HDAC6 axis may offer new opportunities for disease-modifying treatments in PD.https://doi.org/10.1186/s12967-025-06602-3Parkinson’s diseaseCircPRDM5MiR-433-3pHDAC6AutophagyApoptosis
spellingShingle Kai Wang
Langfeng Zhu
Zhibo Ren
CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis
Journal of Translational Medicine
Parkinson’s disease
CircPRDM5
MiR-433-3p
HDAC6
Autophagy
Apoptosis
title CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis
title_full CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis
title_fullStr CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis
title_full_unstemmed CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis
title_short CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis
title_sort circprdm5 mediated regulation of mir 433 3p and hdac6 in parkinson s disease a novel neuroprotective axis
topic Parkinson’s disease
CircPRDM5
MiR-433-3p
HDAC6
Autophagy
Apoptosis
url https://doi.org/10.1186/s12967-025-06602-3
work_keys_str_mv AT kaiwang circprdm5mediatedregulationofmir4333pandhdac6inparkinsonsdiseaseanovelneuroprotectiveaxis
AT langfengzhu circprdm5mediatedregulationofmir4333pandhdac6inparkinsonsdiseaseanovelneuroprotectiveaxis
AT zhiboren circprdm5mediatedregulationofmir4333pandhdac6inparkinsonsdiseaseanovelneuroprotectiveaxis